High-throughput viability assays are a cornerstone of screening cascades to guide SAR in oncology drug development. In the early stages of drug discovery, cell-based assays are indispensable for understanding the functional effects of new therapeutic agents. Our portfolio encompasses high-throughput assays to assess fundamental cell health indicators such as proliferation, viability and cytotoxicity, as well as more complex assays to quantify cell cycle alterations, senescence, apoptosis and more.